Richard Daniell

EVP, Europe Commercial, Teva Pharmaceuticals

Bought, 12 months

$0.0M

Sold, 12 months

$12.1M

Companies

Latest trade

May 5, 2026

Companies

Teva PharmaceuticalsEVP, Europe Commercial −$12.1M

Trades

TEVA Sold 30,000 shares at $35.40 $1.1M May 5

TEVA Sold 17,295 shares at $31.67 · planned $0.5M Mar 5

TEVA Sold 91,345 shares at $32.66 · planned $3.0M Mar 4

TEVA Sold 128,985 shares at $32.36 · planned $4.2M Mar 3

TEVA Sold 115,468 shares at $28.68 $3.3M Dec 9

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.